Literature DB >> 1847375

Mutations in the autoinhibitor site of the regulatory subunit of cAMP-dependent protein kinase I. Replacement of Ala-97 and Ser-99 interferes with reassociation with the catalytic subunit.

Y J Buechler1, S S Taylor.   

Abstract

Each regulatory (R) subunit of cAMP-dependent protein kinase contains an autoinhibitor site that lies approximately 90-100 residues from the amino terminus. In order to study the importance of this autoinhibitor site in the type I R-subunit for interacting with the catalytic (C) subunit, recombinant techniques were used to replace Ala-97 with Gln, His, Lys, and Arg and to replace Ser-99 with Gly and Lys. All of the mutant proteins having a replacement at Ala-97 showed reduced affinity for the C-subunit ranging from 14- to 55-fold. In general, the decrease in affinity of the Ala-97 mutants for the C-subunit correlated with the increase in size of the side chain. In contrast to wild type R-subunit, where MgATP facilitates holoenzyme formation, MgATP inhibits the reassociation in all of the Ala-97 mutants suggesting that the larger side chains sterically interfere with bound MgATP in the active site of the C-subunit. Whereas MgATP slowed holoenzyme formation, AMP actually accelerated the reassociation of the A97K, A97H (pH 6.0), and A97Q mutants with the C-subunit. Therefore, the side chains of Lys-97, His-97, and Gln-97 can interact either electrostatically or by hydrogen bonding with the phosphate of AMP. This interpretation is reinforced by the fact that the stimulatory effect of AMP on the A97H mutant was pH-dependent. The affinities of the S99G and S99K mutants for the C-subunit were reduced 7- and 24-fold, respectively, suggesting that Ser-99 also may contribute to interactions between the R- and C-subunits.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847375

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Mobilization of the A-kinase N-myristate through an isoform-specific intermolecular switch.

Authors:  M Gangal; T Clifford; J Deich; X Cheng; S S Taylor; D A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  p90 ribosomal S6 kinase 1 (RSK1) and the catalytic subunit of protein kinase A (PKA) compete for binding the pseudosubstrate region of PKAR1alpha: role in the regulation of PKA and RSK1 activities.

Authors:  Xianlong Gao; Deepti Chaturvedi; Tarun B Patel
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

3.  Investigating PKA-RII specificity using analogs of the PKA:AKAP peptide inhibitor STAD-2.

Authors:  N George Bendzunas; Sabrina Dörfler; Karolin Autenrieth; Daniela Bertinetti; Erik M F Machal; Eileen J Kennedy; Friedrich W Herberg
Journal:  Bioorg Med Chem       Date:  2018-02-12       Impact factor: 3.641

4.  The PKARIalpha subunit of protein kinase A modulates the activation of p90RSK1 and its function.

Authors:  Deepti Chaturvedi; Michael S Cohen; Jack Taunton; Tarun B Patel
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

5.  Bacterial expression of Chinese hamster regulatory type-I and catalytic subunits of cyclic AMP-dependent protein kinase and mutational analysis of the type-I regulatory subunit.

Authors:  M E Gosse; R Fleischmann; M Marshall; N Wang; S Garges; M M Gottesman
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

6.  Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.

Authors:  J Chen; X F Zheng; E J Brown; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

7.  Active site coupling in PDE:PKA complexes promotes resetting of mammalian cAMP signaling.

Authors:  Srinath Krishnamurthy; Balakrishnan Shenbaga Moorthy; Lim Xin Xiang; Lim Xin Shan; Kavitha Bharatham; Nikhil Kumar Tulsian; Ivana Mihalek; Ganesh S Anand
Journal:  Biophys J       Date:  2014-09-16       Impact factor: 4.033

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.